Direct determination of intracellular daunorubicin in intact confluent monolayers of AT1 prostate carcinoma cells using a multiwell-multilabel counter

Analytical Biochemistry

Volumn 381, Issue 1, 2008, Pages 81-85

  Sauvant, C ^a   Thews, O ^b   Wirth, C ^a   Gekle, M ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Assay; Cellular content; Cytostatics; Daunorubicin; Multidrug resistance; p Glycoprotein

Indexed keywords

ASSAYS; CELL CULTURE; FLUORESCENCE; GLYCOPROTEINS; MONOLAYERS; TUMORS; UROLOGY;

CELLULAR CONTENT; CYTOSTATICS; DAUNORUBICIN; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN;

CELLS;

CATION; DAUNORUBICIN; DNA; GLYCOPROTEIN P;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL STRAIN AT1; CYTOSTASIS; CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; FLUORESCENCE; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT;

EID: 49049108667     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.06.033     Document Type: Article

References (14)

1. Chang G. Multidrug resistance ABC transporters. FEBS Lett. 555 (2003) 102-105
2. Higgins C.F. ABC transporters: physiology, structure, and mechanism: an overview. Res. Microbiol. 152 (2001) 205-210
3. Higgins C.F. Multiple molecular mechanisms for multidrug resistance transporters. Nature 446 (2007) 749-757
4. Ambudkar S.V., Kimchi-Sarfaty C., Sauna Z.E., and Gottesman M.M. P-glycoprotein: From genomics to mechanism. Oncogene 22 (2003) 7468-7485
5. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55 (2003) 3-29
6. Fojo T., and Bates S. Strategies for reversing drug resistance. Oncogene 22 (2003) 7512-7523
7. Xu R.H., Pelicano H., Zhou Y., Carew J.S., Feng L., Bhalla K.N., Keating M.J., and Huang P. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65 (2005) 613-621
8. Puddu P., Fais S., Luciani F., Gherardi G., Dupuis M.L., Romagnoli G., Ramoni C., Cianfriglia M., and Gessani S. Interferon-(up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages. Lab. Invest. 79 (1999) 1299-1309
9. Yang J.M., Sullivan G.F., and Hait W.N. Regulation of the function of P-glycoprotein by epidermal growth factor through phospholipase C. Biochem. Pharmacol. 53 (1997) 1597-1604
10. Thews O., Gassner B., Kelleher D.K., Schwerdt G., and Gekle M. Impact of extracellular acidity on the activity of p-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8 (2006) 143-152
11. Lee G., and Piquette-Miller M. Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines: analysis using RT-PCR and cDNA microarrays. J. Pharm. Sci. 92 (2003) 2152-2163
12. Lotz C., Kelleher D.K., Gassner B., Gekle M., Vaupel P., and Thews O. Role of tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells. Oncol. Rep. 17 (2007) 239-244
13. Lee R.K., Lui P.P., Ngan E.K., Lui J.C., Suen Y.K., Chan F., and Kong S.K. The nuclear tubular invaginations are dynamic structures inside the nucleus of HeLa cells. Can. J. Physiol. Pharmacol. 84 (2006) 477-486
14. Weber F., Freudinger R., Schwerdt G., and Gekle M. A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substances. Toxicol. In Vitro 19 (2005) 135-143